Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
RGN-352 was shown to be safe and well-tolerated with no serious drug-related adverse events reported (PMID: 20536472) Phase 2 AMI trial (incomplete): RegeneRx designed a Phase 2 proof-of-concept trial (NCT01311518) to evaluate RGN-352 in approximately 75 patients with acute ST-segment elevation myocardial infarction (heart attack)
When prescribed by a licensed physician for legitimate medical purposes and sourced through a compliant pharmacy, it can be used clinically
B12 Injections and Travel: Timing, Safety, and Staying Energised on Your Summer Break Summer travel often involves long flights, busy sightseeing schedules, and changes in sleep patterns
If you plan to resume, restart at the full dose rather than titrating back up, since the break period allows receptor resensitization
Most regulars are in and out in under ten minutes
